Different therapeutic strategies for burning mouth syndrome: Preliminary data

Journal of Oral Pathology and Medicine

Volumn 39, Issue 8, 2010, Pages 611-616

  Marino, Roberto ^a,b   Torretta, Sara ^c   Capaccio, Pasquale ^c   Pignataro, Lorenzo ^c   Spadari, Francesco ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

lipoic acid; burning mouth syndrome; capsaicin; lisozime lactoperoxidase; therapy

Indexed keywords

BIOTENE; BORIC ACID; CAPSAICIN; LYSOZYME; THIOCTIC ACID; TIOBEC; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BURNING MOUTH SYNDROME; CLINICAL TRIAL; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; VISUAL ANALOG SCALE; XEROSTOMIA;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANTIOXIDANTS; BORIC ACIDS; BURNING MOUTH SYNDROME; CAPSAICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; LACTOPEROXIDASE; MALE; MIDDLE AGED; MOUTHWASHES; MURAMIDASE; PAIN MEASUREMENT; PLACEBOS; PROSPECTIVE STUDIES; SENSORY SYSTEM AGENTS; SINGLE-BLIND METHOD; TABLETS; THIOCTIC ACID;

EID: 77956269914     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2010.00922.x     Document Type: Article

References (47)

1. Patton LL, Siegel MA, Benoliel R, et al. Management of burning mouth syndrome: systematic review and management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 103 (Suppl S39.e1 13.
2. Merskey H, Bugduk N. Task on taxonomy. Seattle: classification of chronic pain. Description of chronic pain syndromes and definition of pain terms. Seattle : IASP press, 1994 742.
3. Mignogna MD, Fedele S, Lo Russo L. The diagnosis of burning mouth syndrome represents a challenge for clinicians. J Orofac Pain 2005 19 : 168 173.
4. Lamey PJ, Lamb AB. Prospective study of aetiological factors in burning mouth syndrome. BMJ 1988 296 : 1243 1246.
5. Scala A, Checchi L, Montevecchi M, et al. Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med 2003 14 : 275 291.
6. Sardella A, Lodi G, Demarosi F, et al. Causative or precipitating aspects of burning mouth syndrome: a case-control study. J Oral Pathol Med 2006 35 : 466 471.
7. Sardella A, Lodi G, Demarosi F. Burning Mouth Syndrome: a retrospective study on spontaneous remission. Oral Dis 2006 12 : 152 155.
8. Albuquerque RJ, de Leeuw R, Carlson CR, et al. Cerebral activation during thermal stimulation of patients who have burning mouth disorder: an fMRI study. Pain 2006 122 : 223 234.
9. Jaaskelainen SK, Forssell H, Tenovuo O. Abnormalities of the blink reflex in burning mouth syndrome. Pain 1997 73 : 455 460.
10. Forssell H, Jaaskelainen S, Tenovuo O, Hinkka S. Sensory dysfunction in burning mouth syndrome. Pain 2002 99 : 41 7.
11. Hagelberg N, Forssell H, Rinnec JO, et al. Striatal dopamine D1 and D2 receptors in burning mouth syndrome. Pain 2003 101 : 149 154.
12. Groushka M, Bartoshuk LM. Burning mouth syndrome and oral dysaesthesia: taste injury is a piece of puzzle. Can J Diagn 2000 17 : 99 109.
13. Lauria G, Maiorana A, Borgna M, et al. Trigeminal small fiber sensory neuropathy causes burning mouth syndrome. Pain 2005 115 : 332 337.
14. Bergdahl J, Anneroth G, Perris H. Cognitive therapy in the treatment of patients with resistant burning mouth syndrome: a controlled study. J Oral Pathol Med 1995 24 : 213 215.
15. Pokupec-Gruden JS, Cekic-Arambasin A, Gruden V. Psychogenic factors in the aetiology of stomatopyrosis. Coll Antropol 2000 24 : 119 126.
16. Nicholson M, Wilkinson G, Field E, et al. A pilot study: stability of psychiatric diagnoses over 6 months in burning mouth syndrome. J Psychosom Res 2000 49 : 1 2.
17. Abetz LM, Savage NW. Burning mouth syndrome and psychological disorders. Aust Dent J 2009 54 : 84 93.
18. Dieb Miziara I, Cunha Araújo Filho B, Oliveira R, Rodrigues dos Santos RM. Group psychotherapy: an additional approach to burning mouth syndrome. J Psychosom Res 2009 69 : 443 448.
19. Fedele S, Fricchione G, Porter SR, Mignogna MD. Burning mouth syndrome (stomatodynia). Q J Med 2007 100 : 527 530.
20. Sardella A. An up-to-date view on burning mouth syndrome. Minerva Stomatol 2007 56 : 327 340.
21. Tourne LP, Fricton JR. Burning mouth syndrome. Critical review and proposed clinical management. Oral Surg Oral Med Oral Pathol 1992 74 : 158 167.
22. Maina G, Vitalucci A, Gandolfo S, et al. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study. J Clin Psychiatr 2002 63 : 38 43.
23. Grushka M, Epstein J, Mott A. An open label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998 86 : 557 561.
24. Guarneri F, Guarneri C, Marini H. Contribution of neuroinflammation in burning mouth syndrome: indications from benzodiazepine use. Dermatol Ther 2008 2 : S21 4.
25. Grémeau-Richard C, Dubray C, Aublet-Cuvelier B, et al. Effect of lingual nerve block on burning mouth syndrome (stomatodynia): a randomized crossover trial. Pain 2010 149 : 27 32.
26. Gremeau-Richard C, Woda A, Navez ML, et al. Topical clonazepam in stomatodynia: a randomised placebo-controlled study. Pain 2004 118 : 51 7.
27. Epstein JB, Marcoe JH. Topical application of capsaicin for treatment of neuropathic pain and trigeminal neuralgia. Oral Surg Oral Med Oral Pathol 1994 77 : 135 140.
28. Scardina GA, Carini F, Valenza V, et al. Topical capsaicin application and axon reflex vasodilatation of the tongue: neurogenic involvement in burning mouth syndrome. Methods Find Exp Clin Pharmacol 2006 28 : 707 711.
29. Femiano F, Gombos F, Scully C. Burning mouth syndrome (BMS): controlled open trial of the efficacy of alpha-lipoic acid (thioctic acid) on symptomatology. Oral Dis 2000 6 : 274 277.
30. Femiano F, Gombos F, Scully C. Burning mouth syndrome: the efficacy of lipoic acid on subgroups. J Eur Acad Dermatol Venereol 2004 18 : 676 678.
31. Femiano F, Scully C. Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy. J Oral Pathol Med 2002 31 : 267 269.
32. Carbone M, Pentenero M, Carrozzo M, et al. Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a double-blind, randomized, placebo-controlled study. Eur J Pain 2009 13 : 492 496.
33. Cavalcanti DR, da Silveira FRX. Alpha lipoic acid in burning mouth syndrome - a randomized double-blind placebo-controlled trial. J Oral Pathol Med 2009 38 : 254 261.
34. Marques-Soares MS, Chimenos-Küstner E, Subirá-Pifarrè C. Association of burning mouth syndrome with xerostomia and medicines. Med Oral Patol Oral Cir Bucal 2005 10 : 301 308.
35. Kirstilä V, Lenander-Lumikari M, Söderling E. Effects of oral hygiene products containing lactoperoxidase, lysozyme, and lactoferrin on the composition of whole saliva and on subjective oral symptoms in patients with xerostomia. Acta Odontol Scand 1996 54 : 391 397.
36. Tenovuo J. Clinical applications of antimicrobial host proteins lactoperoxidase, lysozyme and lactoferrin in xerostomia: efficacy and safety. Oral Dis 2002 8 : 23 29.
37. Gil-Montoya JA, Guardia-Lopez I, Gonzàlez-Moles MA. Evaluation of the clinical efficacy of a mouthwash and oral gel containing the antimicrobial proteins lactoperoxidase, lysozyme and lactoferrin in elderly patients with dry mouth - a pilot study. Gerodontology 2008 25 : 3 9.
38. Marino R, Capaccio P, Pignataro L, et al. Burning mouth syndrome: the role of contact hypersensitivity. Oral Dis 2009 15 : 255 258.
39. Huskisson EC. Measurement of pain. Lancet 1974 304 : 1127 1131.
40. López-Jornet P. Need for multicenter studies in burning mouth syndrome. J Oral Pathol Med 2008 37 : 445 446.
41. Zakrewska JM. The burning mouth syndrome remains an enigma. Pain 1995 62 : 253 257.
42. Savage NW, Boras V, Barker K. Burning mouth syndrome: clinical presentation, diagnosis and treatment. Australas J Dermatol 2006 2 : 77 81.
43. Sinoff SE, Hart M. Topical capsaicin and burning pain. Clin J Pain 1993 9 : 70 3.
44. Zakrzewska JM, Forssell H, Glenny AM. Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev 2005 25 : CD002779.
45. Padilla M, Clark GT, Merrill RL. Topical medications for orofacial neuropathic pain: a review. J Am Dent Assoc 2000 131 : 184 195.
46. Spice R, Hagen NA. Capsaicin in burning mouth syndrome: titratrion strategies. J Otolaryngol 2004 33 : 53 4.
47. Petruzzi M, Lauritano D, De Benedittis M, et al. Systemic capsaicin for burning mouth syndrome: short-term results of a pilot study. J Oral Pathol Med 2004 33 : 111 114.